Eliminate Rosacea, Redness, and Inflammation with Targeted Energy

Aerolase Neo helps you reduce the erythema, telangiectasias, papules, and pustules of rosacea with quick in-office treatments.

A woman getting a facial peel from a doctor
A woman getting a laser on her face

Take Better Control of Their Rosacea — and Your Profits

Affecting more than 16 million Americans, this chronic, inflammatory disease is often triggered by sun exposure, hot weather, humidity, stress, etc.

Rosacea often comes in many forms:

  • Erythematotelangiectatic Rosacea
  • Ocular Rosacea
  • Phymatous Rosacea

Rosacea oftens goes under recognized in skin of color and darker skin tones since it's presented differently.

How Aerolase Technology Helps Reduce Rosacea

The 650-Microsecond pulsed 1064nm energy offers efficient heating of the targeted chromophore. The laser energy gently coagulates vessels, veins, and angiomas. The energy is delivered more quickly into the target and providing less time to be lost to the surrounding tissue via thermal transfer. Leading the lesions to slough off or be absorbed by the body's natural immune response.

A man getting a laser on his forehead

Customer testimonials

"Rosacea chronically returns and, if it does, it's easy to bring your patients in and take care of it immediately with the Neo."
Michael Gold
MD
"[With the Neo], substantial or even complete clearance can be achieved in just a single treatment. "My patients are amazed at how effective and tolerable their rosacea treatments are with Neo aesthetic laser. They feel a warm sensation but no skin contact during treatment, so it's pleasant and sanitary and also very quick."
Yelena Kipervas
DO
"The Neo allowed for the removal of rosacea in a quick but gentle procedure. Spider veins and other vessels can be cleared in 1 to 3 treatments. My patients are ecstatic with the results."
Ingeborg Dziedzic
MD

Let’s Discuss Your Treatment Strategy

Transform Your Rosacea, Redness & Inflammation Strategy

Enhance patient outcomes and boost your practice revenue.